Radiation therapy in the treatment of cholangiocarcinoma
- PMID: 16922259
Radiation therapy in the treatment of cholangiocarcinoma
Abstract
The prognosis of patients with biliary cancers is poor. Although surgery is potentially curative in selected patients, local recurrence is a common pattern of failure. Adjuvant or neoadjuvant radiation therapy improves local control and possibly survival. In locally advanced patients, radiation therapy provides palliation and may prolong survival. Concurrently administered chemotherapy may further enhance these results. Newer radiation therapy techniques, including intraluminal transcatheter brachytherapy, intraoperative radiation therapy, intensity-modulated radiation therapy, and three- and four-dimensional treatment planning, permit radiation dose escalation without significant increases in normal tissue toxicity, thereby increasing the effective radiation dose. Preliminary results of studies employing hepatic transplantation with radiation therapy are encouraging. Although these new approaches hold promise, the prognosis in patients with biliary cancers remains poor, and the integration of novel therapeutic strategies is indicated.
Similar articles
-
Patterns of failure following surgical resection for malignant pleural mesothelioma.Thorac Surg Clin. 2004 Nov;14(4):567-73. doi: 10.1016/j.thorsurg.2004.06.006. Thorac Surg Clin. 2004. PMID: 15559064 Review.
-
External radiotherapy and brachytherapy in the management of extrahepatic and intrahepatic cholangiocarcinoma: available evidence.Br J Radiol. 2017 Aug;90(1076):20170061. doi: 10.1259/bjr.20170061. Epub 2017 May 23. Br J Radiol. 2017. PMID: 28466653 Free PMC article. Review.
-
Brachytherapy and percutaneous stenting in the treatment of cholangiocarcinoma: a prospective randomised study.Eur J Radiol. 2007 May;62(2):175-9. doi: 10.1016/j.ejrad.2007.01.037. Epub 2007 Mar 6. Eur J Radiol. 2007. PMID: 17344008 Clinical Trial.
-
Intraluminal high dose rate brachytherapy in the treatment of bile duct and gallbladder carcinomas.Hepatogastroenterology. 2002 Jul-Aug;49(46):916-7. Hepatogastroenterology. 2002. PMID: 12143240
-
The multidisciplinary management of gastrointestinal cancer. Biliary tract cancers: from pathogenesis to endoscopic treatment.Best Pract Res Clin Gastroenterol. 2007;21(6):1015-29. doi: 10.1016/j.bpg.2007.09.005. Best Pract Res Clin Gastroenterol. 2007. PMID: 18070701 Review.
Cited by
-
Cholangiocarcinoma--controversies and challenges.Nat Rev Gastroenterol Hepatol. 2011 Apr;8(4):189-200. doi: 10.1038/nrgastro.2011.20. Nat Rev Gastroenterol Hepatol. 2011. PMID: 21460876 Free PMC article. Review.
-
NCCN clinical practice guidelines in oncology: hepatobiliary cancers.J Natl Compr Canc Netw. 2009 Apr;7(4):350-91. doi: 10.6004/jnccn.2009.0027. J Natl Compr Canc Netw. 2009. PMID: 19406039 Free PMC article. No abstract available.
-
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2019.Curr Oncol. 2021 May 26;28(3):1988-2006. doi: 10.3390/curroncol28030185. Curr Oncol. 2021. PMID: 34073199 Free PMC article.
-
Resectable Cholangiocarcinoma: Reviewing the Role of Adjuvant Strategies.Clin Med Insights Oncol. 2016 May 12;10:43-8. doi: 10.4137/CMO.S32821. eCollection 2016. Clin Med Insights Oncol. 2016. PMID: 27199577 Free PMC article. Review.
-
Emerging molecular targets and therapy for cholangiocarcinoma.World J Gastrointest Oncol. 2017 Jul 15;9(7):268-280. doi: 10.4251/wjgo.v9.i7.268. World J Gastrointest Oncol. 2017. PMID: 28808500 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources